# Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients

> **NCT02062892** · PHASE4 · WITHDRAWN · sponsor: **University of Colorado, Denver**

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT02062892
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-12
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Patients meeting the inclusion/ exclusion criteria did not agree to participate. It became obvious that recruitment goals could not be met.
- **Last updated:** 2014-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062892, "Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02062892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*